DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

B. Riley Downgrades Global Medical REIT to Neutral, Raises Price Target to $16

B. Riley analyst Bryan Maher downgrades Global Medical REIT (NYSE:GMRE) from Buy to Neutral and raises the price target from $15 to $16.

Benzinga · 03/06/2020 12:15

B. Riley analyst Bryan Maher downgrades Global Medical REIT (NYSE:GMRE) from Buy to Neutral and raises the price target from $15 to $16.